Ovarian Cancer: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan Kettering's clinical trials for ovarian cancer. To learn more about a study, choose from the list below.

Showing 30 trials
Title Investigatorsort icon
A Phase I Study of AM0010 in Patients with Advanced Solid Tumors
[Protocol 13-224]
Autio, Karen, MD
A Phase II Study of Rucaparib in Patients Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Relapsed/Refractory
[Protocol 13-255]
Bell-McGuinn, Katherine, MD, PhD
A Phase III Study of Olaparib vs Placebo as Maintenance Therapy in Women with BRCA-Mutated Advanced Ovarian Cancer After Platinum-Based Chemotherapy
[Protocol 14-036]
Bell-McGuinn, Katherine, MD, PhD
A Phase III Study of Rucaparib after Platinum-Based Chemotherapy in Women with High-Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 14-067]
Bell-McGuinn, Katherine, MD, PhD
A Phase I Study of Carboplatin/Paclitaxel/Bevacizumab and ABT-888 in Patients with Previously Untreated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 09-106]
Bell-McGuinn, Katherine, MD, PhD
A Phase I Study of BKM120 and Olaparib in Patients with High-Grade Serous Ovarian Cancer
[Protocol 12-233]
Bell-McGuinn, Katherine, MD, PhD
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 13-198]
Callahan, Margaret, MD, PhD
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
[Protocol 08-155]
Chi, Dennis, MD
A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Relapsed/Refractory
[Protocol 12-275]
Chi, Dennis, MD
A Pilot Study Assessing PET Probes to Detect Cancerous Tissue During Surgery for Recurrent Ovarian Cancer
[Protocol 13-017]
Chi, Dennis, MD
A Phase I Study of Lurbinectedin plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 13-170]
Drilon, Alexander, MD
A Phase II Study of Enzalutamide in Patients with Advanced or Recurrent Androgen Receptor-Positive Ovarian Cancer
[Protocol 13-119]
Grisham, Rachel, MD
A Phase II Study of Pimasertib with SAR245409 or a Placebo in Women with Previously Treated Inoperable Low-Grade Ovarian Cancer
[Protocol 13-173]
Grisham, Rachel, MD
A Phase IB Study of MEK162 plus Paclitaxel in Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-192]
Grisham, Rachel, MD
A Phase III Study of MEK162 versus Standard Chemotherapy in Patients with Recurrent or Persistent Low-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: The MILO Study
[Protocol 13-098]
Grisham, Rachel, MD
A Phase II Study of Neratinib in Patients with Solid Tumors Containing Mutated HER2
[Protocol 13-140]
Hyman, David, MD
A Phase II Study of Dasatinib to Treat Recurrent Clear Cell Cancer of the Ovaries or Endometrium
[Protocol 14-008]
Hyman, David, MD
A Phase III Study of Doxil with and without Vintafolide in Women with Platinum-Resistant Ovarian Cancer
[Protocol 13-046]
Konner, Jason, MD
A Phase IB Study of REGN910 and Aflibercept plus Paclitaxel in Women with Recurrent Ovarian Cancer
[Protocol 13-156]
Konner, Jason, MD
Phase I Study of Olaparib in Combination with Chemotherapy in Patients Newly Diagnosed with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 10-220]
Konner, Jason, MD
A Phase II Study of Paclitaxel/Carboplatin versus Bleomycin/Etoposide/Cisplatin for Patients with Advanced Ovarian Stromal Tumors Who Have Not Received Chemotherapy
Relapsed/Refractory
[Protocol 13-177]
Leitao, Mario, MD
A Phase II Study of Dalantercept for Treating Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 13-109]
Makker, Vicky, MD
A Phase II Study of BYL719 plus AMG 479 (Ganitumab) in Patients with Advanced Ovarian Cancer or Hormone Receptor-Positive Breast Cancer
[Protocol 13-251]
Modi, Shanu, MD
A Phase I Study of DLYE5953A in Patients with Advanced or Persistent Solid Tumors
[Protocol 14-089]
Modi, Shanu, MD
A Phase III Study of Doxil Alone and with Yondelis (Trabectedin) in Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 13-153]
O'Cearbhaill, Roisin, MB BCh BAO
A Phase Ib Study of OMP-54F28 with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
[Protocol 14-029]
O'Cearbhaill, Roisin, MB BCh BAO
Standard Infusion Carboplatin versus Prophylactic Extended Infusion Carboplatin in the Treatment of Patients with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
[Protocol 10-184]
O'Cearbhaill, Roisin, MB BCh BAO
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051]
Offit, Kenneth, MD
A Phase I Study of Lirilumab plus Nivolumab in Patients with Advanced Solid Tumors
[Protocol 12-224]
Segal, Neil, MD, PhD
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women with Ovarian Cancer
[Protocol 11-164]
Tew, William, MD